These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 23273243)

  • 21. Adapting the Aerogen Mesh Nebulizer for Dried Aerosol Exposures Using the PreciseInhale Platform.
    Gerde P; Nowenwik M; Sjöberg CO; Selg E
    J Aerosol Med Pulm Drug Deliv; 2020 Apr; 33(2):116-126. PubMed ID: 31613690
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of nebulizer type, delivery interface, and flow rate on aerosol drug delivery to spontaneously breathing pediatric and infant lung models.
    Ari A
    Pediatr Pulmonol; 2019 Nov; 54(11):1735-1741. PubMed ID: 31313534
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decrease the flow setting to improve trans-nasal pulmonary aerosol delivery via "high-flow nasal cannula" to infants and toddlers.
    Li J; Gong L; Ari A; Fink JB
    Pediatr Pulmonol; 2019 Jun; 54(6):914-921. PubMed ID: 30920155
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Devices for Improved Delivery of Nebulized Pharmaceutical Aerosols to the Lungs.
    Longest W; Spence B; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2019 Oct; 32(5):317-339. PubMed ID: 31287369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development of Dry Powder Inhaler Patient Interfaces for Improved Aerosol Delivery to Children.
    Bass K; Longest W
    AAPS PharmSciTech; 2020 May; 21(5):157. PubMed ID: 32451773
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aerosol Therapy in Adults Receiving High Flow Nasal Cannula Oxygen Therapy.
    Réminiac F; Vecellio L; Heuzé-Vourc'h N; Petitcollin A; Respaud R; Cabrera M; Pennec DL; Diot P; Ehrmann S
    J Aerosol Med Pulm Drug Deliv; 2016 Apr; 29(2):134-41. PubMed ID: 26196740
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of enhanced condensational growth (ECG) for controlled respiratory drug delivery in a mouth-throat and upper tracheobronchial model.
    Hindle M; Longest PW
    Pharm Res; 2010 Sep; 27(9):1800-11. PubMed ID: 20454837
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro comparison of unit dose vs infusion pump administration of albuterol via high-flow nasal cannula in toddlers.
    Li J; Wei W; Fink JB
    Pediatr Pulmonol; 2020 Feb; 55(2):322-329. PubMed ID: 31782914
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hood nebulization: effects of head direction and breathing mode on particle inhalability and deposition in a 7-month-old infant model.
    Kim J; Xi J; Si X; Berlinski A; Su WC
    J Aerosol Med Pulm Drug Deliv; 2014 Jun; 27(3):209-18. PubMed ID: 23808762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influences of cannula size and flow rate on aerosol drug delivery through the Vapotherm humidified high-flow nasal cannula system.
    Perry SA; Kesser KC; Geller DE; Selhorst DM; Rendle JK; Hertzog JH
    Pediatr Crit Care Med; 2013 Jun; 14(5):e250-6. PubMed ID: 23628834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quantifying continuous nebulization via high flow nasal cannula and large volume nebulizer in a pediatric model.
    Moody GB; Ari A
    Pediatr Pulmonol; 2020 Oct; 55(10):2596-2602. PubMed ID: 32681768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterizing the Effects of Nasal Prong Interfaces on Aerosol Deposition in a Preterm Infant Nasal Model.
    Bass K; Momin MAM; Howe C; Aladwani G; Strickler S; Kolanjiyil AV; Hindle M; DiBlasi RM; Longest W
    AAPS PharmSciTech; 2022 Apr; 23(5):114. PubMed ID: 35441324
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparative
    Valencia-Ramos J; Arnaez J; Benito JM; Mirás A; Ochoa C; Beltrán S
    Exp Lung Res; 2019; 45(1-2):13-21. PubMed ID: 31007091
    [No Abstract]   [Full Text] [Related]  

  • 34. Albuterol Delivery Efficiency in a Pediatric Model of Noninvasive Ventilation With Double-Limb Circuit.
    Velasco J; Berlinski A
    Respir Care; 2018 Feb; 63(2):141-146. PubMed ID: 29114011
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting aerosol deposition to and within the lung airways using excipient enhanced growth.
    Tian G; Longest PW; Li X; Hindle M
    J Aerosol Med Pulm Drug Deliv; 2013 Oct; 26(5):248-65. PubMed ID: 23286828
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Vitro Characterization of Aerosolized Albuterol Generated by a Jet Nebulizer and Delivered through a Heated Flow Nasal Cannula System.
    Berlinski A; Spiva J
    Pharmaceuticals (Basel); 2022 Oct; 15(10):. PubMed ID: 36297393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Nasal High-Flow Nebulization for Lung Drug Delivery: Theoretical, Experimental, and Clinical Application.
    Dugernier J; Reychler G; Vecellio L; Ehrmann S
    J Aerosol Med Pulm Drug Deliv; 2019 Dec; 32(6):341-351. PubMed ID: 31084452
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generating Charged Pharmaceutical Aerosols Intended to Improve Targeted Drug Delivery in Ventilated Infants.
    Holbrook L; Hindle M; Longest PW
    J Aerosol Sci; 2015 Oct; 88():35-47. PubMed ID: 26273108
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mechanisms of pharmaceutical aerosol deposition in the respiratory tract.
    Cheng YS
    AAPS PharmSciTech; 2014 Jun; 15(3):630-40. PubMed ID: 24563174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study of simulated nebulized and spray particle deposition in chronic rhinosinusitis patients.
    Farzal Z; Basu S; Burke A; Fasanmade OO; Lopez EM; Bennett WD; Ebert CS; Zanation AM; Senior BA; Kimbell JS
    Int Forum Allergy Rhinol; 2019 Jul; 9(7):746-758. PubMed ID: 30821929
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.